Preoperative Cardiac Risk Assessment

Author/s: 
Raslau, D, Bierle, DM, Stephenson, CR, Mikhail, MA, Kebede, EB, Mauck, KF
Date Added: 
February 27, 2020
Journal/Publication: 
Mayo Clinic Proceedings
Publisher: 
Elsevier B.V. / Mayo Foundation for Medical Education and Research
Publication Date: 
February 24, 2020
Type: 
Meta-analyses, Reviews, and Guidelines
Format: 
Article
DOI (1): 
10.1016/j.mayocp.2019.08.013

RPR Commentary

This is a review of the latest recommendations regarding the cardiac assessment of patients needing surgery.  James W. Mold, MD, MPH

Abstract

Major adverse cardiac events are common causes of perioperative mortality and major morbidity. Preventing these complications requires thorough preoperative risk assessment and postoperative monitoring of at-risk patients. Major guidelines recommend assessment based on a validated risk calculator that incorporates patient- and procedure-specific factors. American and European guidelines define when stress testing is needed on the basis of functional capacity assessment. Favoring cost-effectiveness, Canadian guidelines instead recommend obtaining brain natriuretic peptide or N-terminal prohormone of brain natriuretic peptide levels to guide postoperative screening for myocardial injury or infarction. When conditions such as acute coronary syndrome, severe pulmonary hypertension, and decompensated heart failure are identified, nonemergent surgery should be postponed until the condition is appropriately managed. There is an evolving role of biomarkers and myocardial injury after noncardiac surgery to enhance risk stratification, but the effect of interventions guided by these strategies is unclear.

Text Availability

Free full text